glp-1 telehealth crackdown news today FDA Compounding FDA warnings against compounded GLP-1s

Punchline: Facing scrutiny and competition, telehealth companies are finding new ways to pull users into their ecosystems.

A medicine only helps if the patient actually takes it. When looking at the next research steps for elecoglipron, Carroll said he would like to see a phase 3 clinical trial involving thousands of patients over a year or more, to see where the blood-sugar and weight effects actually land and hold

The ecosystem now encompasses pharmaceutical manufacturers (Novo Nordisk, Eli Lilly), compounding pharmacies exploiting regulatory gray areas, telehealth platforms bypassing traditional gatekeepers, medical spas medicalizing wellness, established weight-loss companies pivoting their business models, and retailers experimenting with direct distribution

Accessed at www.verywellhealth.com/fake-ozempic-8553313